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Cytochrome P-450 1A2 (CYP1A2) is a
member of the cytochrome P-450 superfamily
of isozymes. It is involved in the metabolic
activation of several carcinogens such as aro-
matic and heterocyclic amines, nitrosamines,
and mycotoxins (Eaton et al. 1995). In
humans, CYP1A2 has been detected primarily
in the liver, in contrast to the closely related
CYP1A1, which is expressed in extrahepatic
tissues such as lung, placenta, and lymphocytes
(Kawajiri 1999). The induction of CYP1A2
has been reported as a consequence of cigarette
smoking (Kalow and Tang 1991a; Kotake
et al. 1982), the consumption of certain food-
stuffs such as charbroiled meat (Conney et al.
1976) and cruciferous vegetables (Pantuck
et al. 1979; Vistisen et al. 1992), and therapeu-
tic drugs such as rifamin (Wietholtz et al.
1995), carbamazepine (Parker et al. 1998), and
omeprazole (Rost et al. 1994). There is wide
variability in CYP1A2 expression among indi-
viduals in most ethnic and racial groups stud-
ied (Landi et al. 1999), but other than a rare
point mutation detected among the Chinese
(Huang et al. 1999), no genetic polymor-
phisms for CYP1A2 have been identified
(Nakajima et al. 1994).
Like CYP1A1, CYP1A2 is thought to be
induced by exposure to xenobiotics such as
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),
polychlorinated biphenyls (PCBs), and other
structurally related chemicals that have the
ability to bind to the aryl hydrocarbon (Ah)
receptor. The evidence for this belief is derived
primarily from animal models (Safe 1994) or
in vitro studies of mRNA or enzyme levels in
treated human liver cells (Lake et al. 1996;
Zeiger et al. 2001). Very few studies have
investigated in vivo CYP1A2 activity in
humans exposed to TCDD, PCBs, or related
chemicals, and the results have been contradic-
tory. For example, Lambert et al. (1990) found
that persons exposed to polybrominated
biphenyls (PBBs) in Michigan had higher lev-
els of CYP1A2-dependent caffeine metabolism
than did unexposed controls, but no signifi-
cant associations were observed between caf-
feine metabolism and serum TCDD levels
among exposed chemical workers (Halperin
et al. 1995). The present study addresses the
question of whether PCB exposure has affected
in vivo CYP1A2 activity among Mohawk men
and women at Akwesasne.
Akwesasne is a Native American commu-
nity of > 10,000 persons located along the St.
Lawrence River in New York and in Ontario
and Quebec, Canada (Figure 1). Less than
100 ft to the west of Akwesasne is the General
Motors–Central Foundry Division Superfund
hazardous waste site. This facility used
Aroclor 1248, a commercial mixture of vari-
ous PCB congeners, as a hydraulic ﬂuid in its
die-casting machines from 1959 to 1974
(Lacetti 1993). When these machines leaked,
the ﬂuids were collected in the wastewater sys-
tem and disposed of on the property. In the
past, concentrations of PCBs have ranged up
to 40,000 ppm in on-site soils and sludges,
and up to 5,700 ppm offshore in St. Lawrence
River sediment (RMT 1986). The Aluminum
Company of America (ALCOA) operates two
aluminum-processing facilities in the area
(ALCOA Plant West and ALCOA Plant East,
the latter being formerly operated by Reynolds
Metals, Inc.) and also has used Aroclor 1248
in its heat-transfer equipment. These facilities
also have released PCBs into the St. Lawrence
and its tributaries (Ecology and Environment
Inc. 1992). The PCBs have entered the local
food chain, with some species of local fish,
reptiles, amphibians, birds, and mammals
having levels that exceed the U.S. Food and
Drug Administration’s tolerance limits for
human consumption of 2 ppm (wet weight)
for local fish and 3 ppm (lipid weight) for
poultry (Skinner 1992; Sloan and Jock 1990).
Dredging of the St. Lawrence River offshore
from the General Motors facility has been
completed, but remedial alternatives for the
St. Lawrence River offshore from Reynolds
and for the Grasse River near ALCOA are still
being evaluated. On-site remediation is com-
plete at Reynolds and ALCOA, but plans for
remedial work at some on-site locations at
General Motors await final review and
approval.
The pollution is a major concern of the
Mohawk people because their tradition and
culture emphasize the interdependence of
humans and the environment and because
many residents formerly depended on local
fish, waterfowl, and mammals for food.
Previous articles described local ﬁsh consump-
tion patterns among 139 Mohawk men
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Cytochrome P-450 1A2 (CYP1A2) is an enzyme involved in the metabolic activation of some
carcinogens and is believed to be induced by xenobiotics. Very few studies, however, have investi-
gated the association between environmental exposures and in vivo CYP1A2 activity in humans.
To address this issue, a study was conducted of CYP1A2 activity among Native Americans
exposed to polychlorinated biphenyls (PCBs) from the consumption of ﬁsh from the St. Lawrence
River. At the Mohawk Nation at Akwesasne (in New York and in Ontario and Quebec, Canada),
103 adults were interviewed, and they donated blood for serum PCB analysis and underwent the
caffeine breath test (CBT), a safe and noninvasive procedure that uses caffeine as a probe for
CYP1A2 activity in vivo. The results supported the ﬁndings of other studies that CBT values are
higher among smokers and men and lower among women who use oral contraceptives. Despite a
relatively low average total PCB body burden in this population, the sum of serum levels for nine
mono- or di-ortho-substituted PCB congeners showed positive associations with CBT values
(p = 0.052 wet weight and p = 0.029 lipid adjusted), as did toxic equivalent quantities (TEQs;
p = 0.091 for wet weight and 0.048 for lipid adjusted). Regarding individual congeners, serum
levels of PCB-153, PCB-170, and PCB-180 were signiﬁcantly correlated with CBT values. The
results support the notion that CYP1A2 activity may be a marker of an early biological effect of
exposure to PCBs in humans and that the CBT may be a useful tool to monitor such effects.
Key words: cytochrome P-450 1A2, hazardous waste, Indians, North American, PCB, polychlori-
nated biphenyls. Environ Health Perspect 113:272–277 (2005). doi:10.1289/ehp.7370 available via
http://dx.doi.org/ [Online 9 December 2004](Fitzgerald et al. 1996, 1999) and 111 pregnant
Mohawk women (Fitzgerald et al. 2004) and
their association with serum PCB levels. In
these reports we noted a 3-fold decline in the
average rate of local ﬁsh consumption among
both men and women in the past year relative
to > 2 years prior. Such changes may be related
to the advisories that have been issued over the
past decade by Mohawk, state, and provincial
authorities against the consumption of contam-
inated local ﬁsh [New York State Department
of Environmental Conservation (NYSDEC)
2003; New York State Department of Health
(NYSDOH) 2002]. The geometric mean
serum PCB concentration was 2.8 ppb for
men and 1.2 ppb for women. In both cases, a
significant correlation was observed between
estimated cumulative lifetime exposure to
PCBs from local ﬁsh consumption and serum
PCB levels.
In the earlier investigations (Fitzgerald
et al. 1996, 1999, 2004), we used serum PCB
concentrations as a marker of internal dose,
whereas in this study we expanded the focus to
include a measure of an early biological effect
of exposure. More specifically, we tested the
hypothesis that serum PCB levels are positively
correlated with CYP1A2 activity among
Mohawk men and women. We used a breath
test that uses caffeine as a metabolic probe to
safely and noninvasively monitor CYP1A2
activity in vivo (Lambert et al. 1983). The pro-
ject was a collaborative effort among the New
York State Department of Health, the St.
Regis Mohawk Tribe, the Mohawk Council of
Akwesasne, the Akwesasne Task Force on the
Environment, and the State University of New
York at Albany.
Materials and Methods
Ascertainment and interview. Detailed descrip-
tions of ascertainment and interview methods
are published elsewhere (Fitzgerald et al. 1996,
1999, 2004). Brieﬂy, 111 Mohawk women liv-
ing at Akwesasne who became pregnant
between 1 April 1992 and 31 March 1995 were
identified through prenatal care clinics and
other sources, interviewed in the second
trimester, and asked to donate a nonfasting 20
mL venous blood sample for PCB analysis. The
participation rate was 79%. Similarly, 139 adult
Mohawk men, who were the husbands or close
relatives of the women, also took part (partici-
pation rate of 69%). Both the men and women
were asked about demographic characteristics;
height and weight; use of medications; occupa-
tional, residential, and reproductive histories;
recreational pursuits (e.g., gardening, swim-
ming, ﬁshing); alcohol and cigarette use; drink-
ing-water source; and diet, emphasizing local
foods such as ﬁsh, wildlife, meat, dairy prod-
ucts, and fruits and vegetables.
Serum PCB analysis. The blood was
allowed to clot and then centrifuged to provide
10 mL serum. The chemical analysis was per-
formed using methods (including quality
assurance and control, accuracy, and precision)
published elsewhere (Bush et al. 1982, 1984).
Briefly, approximately 10 mL of serum was
extracted using methanol, diethyl ether, and
hexane and then transferred to a Florisil
cleanup column containing 10 g of 4% deacti-
vated Florisil topped with 1 cm anhydrous
sodium sulfate. The eluate was evaporated to
1 mL and analyzed with a Hewlett-Packard
5890 gas chromatograph (Hewlett-Packard,
Houston, TX) using a phenylmethyloctadecyl
silyl-bonded fused-silica capillary column and
an electron-capture detector. A computerized
data management system reported each of
68 PCB-containing zones or peaks and
summed the congener concentrations to report
total PCBs. In some cases, the capillary column
was unable to resolve two or more congeners,
so the result was reported as a mixed peak.
The method detection limit (MDL) for
the 68 congeners in serum ranged from 0.01
to 0.10 ppb, with a median MDL of 0.02 ppb
per congener. However, values less than the
MDL were reported by the laboratory and
included in the statistical analysis. This deci-
sion was based on the fact that many chemists
and statisticians believe that a reported result,
even if it is below the “criterion for detection,”
remains the best available estimate of the true
value and is preferable to assigning an arbitrary
constant such as one-half the detection limit
in the statistical analysis [American Society for
Testing and Materials (ASTM) 1989]. 
In addition to the determination of PCB
congeners, the lipid content of the serum
samples was also measured gravimetrically.
However, given the relatively low lipid con-
tent of serum, this method may be prone to
error. Consequently, serum cholesterol and
triglycerides were measured enzymatically, and
total lipids were calculated using the Centers
for Disease Control and Prevention formula
(Phillips et al. 1989). This change was imple-
mented midway through the study period, so
unfortunately these data were available for
only 46 of the 103 participants.
Caffeine breath test. Medical histories were
taken to identify those with a history of heart
disease, stroke, seizure disorders, uncontrolled
hypertension, arrhythmia, hepatitis, jaundice or
other types of liver disease, adverse reaction to
caffeine, or chemotherapy within the past
5 years that would preclude their participation
in the caffeine breath test (CBT). Those cur-
rently taking prescription medications other
than oral contraceptives and women who were
currently breast-feeding also were excluded.
Participants were asked to refrain from caffeine
consumption for 24 hr and to fast for 8 hr
before the CBT. Height and weight were mea-
sured, and blood pressure and heart rate were
taken to ensure normal readings before the
CBT was administered. Each participant signed
an informed consent and was compensated $30
for his or her time and effort. The women were
tested after they delivered to avoid any potential
risk of the caffeine to the fetus.
The substrate was synthesized (3-13C-
methyl)caffeine (Kotake et al. 1982). The
labeled caffeine dose, 3 mg/kg up to a maxi-
mum of 200 mg, was dissolved in 20 mL
sterile water and ingested by the participants,
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Figure 1. Map of the Mohawk Nation at Akwesasne.
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Paper Millfollowed by ingestion of a 20-mL water wash
of the container. A 20-mL breath sample of
expired air was collected immediately before
and after the ingestion of the labeled caffeine
at 30- and 60-min intervals, and stored in a
Vacutainer. Pharmacologically, the labeled
caffeine is rapidly absorbed and transported to
the liver, where it is metabolized through
3-N-demethylation (Kotake et al. 1982). It
then traverses to the one carbon pool and is
exhaled in the breath as labeled CO2. The
13CO2:12CO2 ratio is determined by differen-
tial gas-isotope ratio mass spectrometry
(Schoeller and Klein 1979). The excess 13C is
calculated from the ratio found in the breath
sample just before and after ingestion of the
substrate and expressed as the dose exhaled per
hour. Because 3-N-demethylation is catalyzed
by CYP1A2, caffeine metabolism reflects
hepatic CYP1A2 activity (Landi et al. 1999).
Statistical analysis. We used multiple
linear regression analysis to test for the associa-
tion between serum PCB concentrations and
the CBT values, after controlling for signifi-
cant background variables that could poten-
tially confound any such association. Potential
confounders consisted of a set of background
variables [age, sex, body mass index (BMI),
cigarette smoking, alcohol consumption, cof-
fee consumption, occupational and recre-
ational exposures to chemicals, medical
conditions, and the use of illicit, prescription,
and over-the-counter drugs], some of which
have been related to CBT values in other stud-
ies (Horn et al. 1995; Kalow and Tang 1991b;
Rost et al. 1994; Vistisen et al. 1992). As an
initial screen, bivariate analyses were con-
ducted to identify variables that were associ-
ated with the CBT values at p < 0.20. These
variables were then regressed on the CBT val-
ues, and backward elimination was used to
delete one at a time those that were associated
at p > 0.10. The serum PCB concentrations
were then added to the model to estimate the
strength of their association with the CBT
values after adjustment for all remaining
background variables. Both the serum PCB
concentrations and CBT values were log-
transformed to normalize their distributions
and stabilize their variances. The inclusion of
the background variables in the final regres-
sion model was confirmed by determining
whether the parameter estimates for the
exposure variables changed by ≥ 10% when
the background variables were deleted
(Rothman and Greenland 1998). 
The serum PCB levels were added to the
regression models in four ways. First, the sum
of concentrations for all 68 congeners was
entered as total PCBs. Second, the sum of
concentrations for the 3 congeners that are
mono-ortho-substituted [International Union
of Pure and Applied Chemistry (IUPAC) con-
geners 105, 118, 167] and the 6 that are
di-ortho-substituted (IUPAC congeners 138,
153, 158, 170, 180, 194) derivatives of
non-ortho-substituted PCBs (ΣPCBs) were
entered. Because the laboratory was not able
to measure the non-ortho-substituted con-
geners themselves, the 9 congeners listed
above (ΣPCBs) represented the subset of the
68 congeners analyzed with the greatest afﬁn-
ity for the Ah receptor and consequently those
that were most likely to induce CYP1A2 activ-
ity. Toxic equivalents (TEQs) were also com-
puted for these nine congeners, using the
World Health Organization (Van den Berg
et al. 1998) toxic equivalency factors (TEFs),
and then added to the regression models.
Finally, individual regression models were also
fitted for individual congeners. However, to
prevent misconceptions regarding the level of
certainty attached to the results, these con-
geners were limited to the five that had a
median or mean concentration that equaled or
exceeded their individual MDL. Additionally,
the regressions were performed using the
serum PCB concentrations of the subset of
46 participants with cholesterol and trigyl-
ceride determinations after expressing their
results as nanograms per gram of lipid.
Results
Of the 250 men and women in the parent
studies, 172 (68.8%) agreed to undergo the
CBT. Of this number, 69 (40.1%) were
determined to be ineligible, yielding a final
sample size of 103. Selected characteristics of
these participants are described in Table 1.
The mean age was 28 years, with a range of
15–67 years. Sixty-two percent were male.
The median percent caffeine dose exhaled in
an hour was 1.6%, with a range of 0.1–6.1%.
Approximately one-half had smoked ciga-
rettes in the past 2 years. Forty-three percent
of the women had taken oral contraceptives
during the past 6 months.
The median serum total PCB level was
1.86 ppb (wet weight), with a maximum of
14.91 ppb (Table 2). The median serum
concentrations for the nine mono- or di-ortho-
substituted congeners ranged from non-
detectable to 0.28 ppb, and their median sum
was 0.83 ppb. The median TEQ for these con-
geners was 0.01 ppt. The most commonly
detected congener was PCB-153, with 95% of
all the samples having a concentration that
exceeded the MDL.
The bivariate analyses revealed that smok-
ers, men, older persons, those with lower body
mass indices, those without a history of hyper-
tension, current coffee drinkers, and those
who did not take antibiotics had higher
median CBT values at p < 0.20. Only smok-
ing and sex, however, were associated with
CBT values at p < 0.10 in the multiple regres-
sion analysis and affected the parameter esti-
mates for serum PCB by ≥ 10% (Table 3).
Consequently, those two factors were included
in the ﬁnal regression models. Among women,
oral contraceptive use was associated with
lower CBT values (p = 0.006) after adjustment
for cigarette smoking. However, this variable
could not be included in the final multiple
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Table 1. Selected characteristics of study participants (63 Mohawk men and 40 Mohawk women),
Akwesasne, 1992–1995.
Characteristica Median Mean ± SE Range
Age (years) 28 30.3 ± 0.9 15–67
BMI (height/weight2) 26.4 27.1 ± 0.4 18.7–38.9
CBT (% dose) 1.6 1.8 ± 0.1 0.1–6.1
Cigarette smoking in past 2 years (% yes) 52.4
Oral contraceptive use in past 6 months (women only, % yes) 42.9
Current alcohol consumption (% yes) 55.0
Current coffee consumption (% yes) 65.5
aSample size < 103 for some characteristics due to missing data. 
Table 2. Serum PCB concentrations (ppb) in Mohawk men (n = 63) and women (n = 40), Akwesasne,
1992–1995.
Congener Median Mean ± SE Range Percent > MDL
PCB-105 < MDL 0.009 ± 0.004 < MDL–0.267 7.8
PCB-118 0.055 0.088 ± 0.015 < MDL–0.881 66.0
PCB-138 0.279 0.390 ± 0.047 < MDL–2.330 80.6
PCB-153 0.258 0.395 ± 0.044 < MDL–2.375 95.1
PCB-158 < MDL 0.007 ± 0.005 < MDL–0.484 7.8
PCB-167 < MDL 0.004 ± 0.002 < MDL–0.134 4.9
PCB-170 < MDL 0.091 ± 0.028 < MDL–2.600 35.0
PCB-180 0.157 0.408 ± 0.064 < MDL–2.948 58.3
PCB-194 < MDL 0.022 ± 0.007 < MDL–0.399 10.7
Total PCBs 1.864 2.808 ± 0.293 0–14.911 99.0a
ΣPCBsb 0.830 1.415 ± 0.164 0–9.206 97.1a
TEQ (ppt) 0.007 0.033 ± 0.007 0–0.558 75.7a
aFor total PCBs, ΣPCBs, and TEQ, values are the percentage of samples with a reportable result, not percentage below
MDL, because MDL is determined only for individual congeners. bSum of IUPAC PCB congeners 105, 118, 138, 153, 158, 167,
170, 180, 194. Article | Fitzgerald et al.
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regression analysis of CBT values on serum
PCB concentrations because this analysis
included both sexes and oral contraceptive use
was restricted to women. It is important to
note, however, that the median CBT value of
1.68 for women who did not use oral contra-
ceptives was identical to that for men, and that
the results of a regression analysis limited to
women and controlling for oral contraceptive
use were similar to those of the final models
for both sexes combined (data not shown).
Table 4 gives the results of the multiple
regression analysis of CBT values on serum
concentrations (both wet weight and lipid
adjusted) of total PCBs, the ΣPCBs, and
TEQs. It also displays the ﬁndings for the ﬁve
individual mono- or di-ortho-substituted con-
geners that had median or mean serum con-
centrations that exceeded their respective
MDLs. After adjusting for cigarette smoking
and sex, serum total PCB was not associated
with CBT values in either the wet-weight or
lipid-adjusted analysis. However, the sum of
the mono- and di-ortho-substituted congeners
was signiﬁcantly related to CBT values in both
analyses. Positive associations were also
observed for PCB-153 (p = 0.045 for wet
weight, p = 0.011 for lipid adjusted), PCB-170
(p = 0.079 for wet weight, p = 0.010 for lipid
adjusted), and PCB-180 (p = 0.086 for wet
weight, p = 0.009 for lipid adjusted). TEQs
were also positively associated with CBT
values (p = 0.091 for wet weight, p = 0.028
for lipid adjusted).
Discussion
The results conﬁrmed other studies indicating
that smoking, sex, and oral contraceptive use
signiﬁcantly impact CBT values. Smoking is a
potent inducer of CYP1A2 (Kalow and Tang
1991a; Kotake et al. 1982), probably due to
polycyclic aromatic hydrocarbons and other
carcinogens found in tobacco smoke. Oral
contraceptive use appears to inhibit CYP1A2
activity in vivo (Abernethy and Todd 1985;
Campbell et al. 1987b; Rietveld et al. 1984),
thereby delaying caffeine metabolism. Some
investigators have attributed the higher CBT
values of men relative to women to parity
(Horn et al. 1995), but oral contraceptives
may also be involved because women who did
not use oral contraceptives had an average
CBT value identical to men in the present
study. Kalow and Tang (1991b) also reported
no principal gender difference when women
using oral contraceptives were excluded from
their analysis.
It is not surprising that serum total PCB
was not related to CBT values because most
of the 68 congeners measured in this investi-
gation are not known to induce CYP1A2.
When the analysis was restricted to the
ΣPCBs believed to have some afﬁnity for the
Ah receptor, however, significant positive
associations were found. To estimate the
dioxin-like activity of these congeners, we cal-
culated TEQs. Although this approach has
uncertainties because of possible nonadditive
effects, differences in the shape of the dose–
response curve, and species responsiveness
(van den Berg et al. 1998), TEQs and CBT
values were positively correlated. In fact, after
lipid adjustment, this relationship was statisti-
cally signiﬁcant, probably because, relative to
the wet-weight analysis, the lipid adjustment
controls for variability in PCB levels due to
differences in lipid content of the nonfasting
serum samples (Phillips et al. 1989).
When the results were restricted to only
those congeners with median serum levels
greater than their MDL, PCB-153, PCB-170,
and PCB-180 were statistically signiﬁcant in
either the wet-weight or lipid-adjusted analysis.
PCB-153 and PCB-180 are persistent con-
geners that, together with PCB-138, were
found in the greatest concentration in
Mohawk serum. These congeners typically are
the most dominant in human tissue worldwide
(Hansen 1999). PCB-170 is also persistent but
usually found in lower concentrations than are
PCB-153 and PCB-180. None of these three
congeners is found in Aroclor 1248 (Frame
et al. 1996), the commercial mixture used
locally, and as such may reﬂect more general
exposures, possibly from Lake Ontario and the
St. Lawrence River (Bush et al. 1985).
PCB-153 and PCB-180 are generally con-
sidered phenobarbital-type inducers of
cytochrome P-450 (Parkinson et al. 1981).
They differ from non-ortho-substituted PCBs,
which are 3-methylcholanthrene-type inducers,
in that they are more likely to induce the
CYP2A family of isozymes than the CYP1A
family (Safe 1994). The other seven mono- and
di-ortho-substituted congeners measured in the
present study, including PCB-170, are mixed
type and induce both families (McFarland and
Clark 1989). The significant association
between PCB-153 and PCB-180 and CBT val-
ues may reﬂect overlap in the ability of PCBs to
induce P-450 enzymes, because phenobarbital-
type inducers may also induce CYP1A to some
extent and methylcholanthrene-type inducers
may induce CYPA2 (Wolff and Toniolo 1995).
Given the tendency of serum concentrations of
individual congeners to be correlated (DeVoto
et al. 1997; Gladen et al. 1999; Koopman-
Esseboom et al. 1994), PCB-153 and PCB-180
may also be proxies for other congeners
that were not measured, especially non-ortho-
substituted congeners that have a high afﬁnity
for the Ah receptor. In fact, Longnecker et al.
(2000) have reported Pearson correlation coef-
ficients between PCB-153 and PCB-180 on
the one hand and selected non-ortho-substi-
tuted PCBs on the other that range from 0.35
to 0.86.
It is important to note that these associa-
tions between serum PCB concentrations and
CBT values were observed despite the relatively
low average body burden of PCBs in this pop-
ulation. The median was 1.8 ppb, which is less
than the general population value of 3.1 ppb
reported by Patterson et al. (1994) during the
same time period. This finding probably
reﬂects the low current rate of local ﬁsh con-
sumption among the Mohawks, a behavioral
change that may be related to the fish advi-
sories issued over the past decade by tribal,
state, and provincial agencies (Fitzgerald et al.
1999, 2004). It is also uncertain whether
Native Americans possess the polymorphisms
that control induction. Such polymorphisms
have not yet been identiﬁed, but in a study of
Table 3. Multiple regression analysis of log-transformed CBT value on background variables in Mohawk
men (n = 63) and women (n = 40), Akwesasne, 1992–1995.
Background variable β-Value SE (β) p-Value
Cigarette smoking in past 2 years (yes/no) 0.360 0.136 0.009
Sex (men/women) 0.303 0.139 0.032
Oral contraceptive use in past 6 months (yes/no)a –0.697 0.234 0.006
β, regression coefﬁcient. 
aWomen only (information on oral contraceptive use was missing for ﬁve women). 
Table 4. Multiple regression analysis of log-transformed CBT valuea on serum PCB concentrations (wet
weight and lipid adjusted) in Mohawk men and women, Akwesasne, 1992–1995.
Wet weight (n = 103) Lipid adjusted (n = 46)
Congener β SE (β) p-Value β SE (β) p-Value
PCB-118 0.030 0.045 0.511 0.185 0.106 0.090
PCB-138 0.017 0.034 0.624 0.215 0.106 0.048
PCB-153 0.145 0.071 0.045 0.346 0.130 0.011
PCB-170 0.084 0.047 0.079 0.324 0.120 0.010
PCB-180 0.080 0.046 0.086 0.207 0.075 0.009
Total PCBs 0.061 0.059 0.306 0.221 0.119 0.070
ΣPCBsb 0.116 0.059 0.052 0.356 0.112 0.003
TEQ 0.054 0.032 0.091 0.154 0.068 0.028
β, regression coefﬁcient. 
aAdjusted for cigarette smoking in the past 2 years and sex. bSum of PCB congeners 105, 118, 138, 153, 158, 167, 170, 180,
and 194. CYP1A2 phenotypes from Australia, China,
Japan, Italy, and the United States, Kadlubar
(1994) found a wide variation in the metabolic
proﬁciency for CYP1A2 within each country.
Although Native peoples were not included,
such results suggest that they, like other racial
and ethnic subgroups, include at least a subset
of inducible persons. Knowledge of which
individuals were genetically capable of induc-
tion would have clearly strengthened the corre-
lations observed in the present study.
Another limitation is the lack of infor-
mation on the concentrations of non-ortho-
substituted congeners in the serum of study
participants. This issue is important because
these congeners are those most likely to induce
CYP1A2 in vitro or in animal models (Safe
1994). Unfortunately, our laboratory was
unable to reliably quantify at the time that the
study was conducted with the very low level of
non-ortho-substituted congeners typically
found in human serum. As noted previously
by Longnecker et al. (2000), however, serum
concentrations of individual congeners tend to
be highly correlated, so persons who had
higher levels of the congeners that were mea-
sured would likely have higher levels of
non-ortho-substituted and any other congeners
that were not determined. Similarly, no serum
data were available for TCDD or other diox-
ins, which are the most potent inducers of
CYP1A2 (Safe 1994). However, not only are
levels of PCB congeners in human serum
intercorrelated, but so are levels of PCBs and
dioxins (Gladen et al. 1999; Koopman-
Esseboom et al. 1994; Patterson et al. 1994);
consequently, the former may also be a surro-
gate for the latter, at least when exposures are
at background levels (Longnecker et al. 2000).
Despite these limitations, the general pat-
tern of results between serum PCB concentra-
tions and CBT values is generally consistent
with at least one of the two other studies that,
to date, have attempted to link xenobiotic
exposure to human CYP1A2 activity in vivo.
Speciﬁcally, Lambert et al. (1990) found that
Michigan residents exposed to PBBs had a sig-
niﬁcantly higher median CBT value than did
a control group of urban nonsmokers. They
also observed a signiﬁcant correlation between
serum PBB levels above the detection limit
and CBT values in the exposed group. In con-
trast, Halperin et al. (1995) found little evi-
dence of an overall association between serum
TCDD concentrations and CYP1A2 activity
among occupationally exposed herbicide
workers. The only suggestion of a relationship
was when three of four categories of workers
deﬁned by increasing concentrations of serum
TCDD showed a greater risk of having an ele-
vated level of CYP1A2 activity relative to
unexposed controls, but the results were not
statistically significant. However, Halperin
et al. (1995) used the caffeine metabolite ratio
(CMR) to indicate in vivo CYP1A2 activity,
not the CBT. The CMR measures caffeine
metabolites in urine, metabolites that are
dependent on different enzymes and pathways
than the CBT (Campbell et al. 1987a). There
is some uncertainty about what metabolites
are most appropriate for the urinary ratio
(Butler et al. 1992) and, although the com-
parative ordering of values is unaffected, the
CMR underestimates the true magnitude of
CYP1A2 activity (Kalow and Tang 1993),
suggesting that it may be a less sensitive indi-
cator than the CBT.
The results of the present study are also
consistent with two other studies that, although
they did not measure in vivo CYP1A2 activity,
did monitor human placental CYP1A1 induc-
tion. Lagueux et al. (1999) found that CYP1A1
activity was elevated in the placental tissue of
Inuit women living in northern Quebec who
are exposed to PCBs and other organochlorine
compounds from the consumption of marine
mammals. Similarly, Lucier et al. (1987)
reported that Yu-Cheng women exposed to
PCBs and dibenzofurans had higher levels of
placental CYP1A1 activity than an unexposed
control group, and that such activity was
inversely correlated with the birth weight of
their offspring.
Conclusion
In conclusion, the results of the present study
support previous observations that smokers
and men have higher levels of in vivo CYP1A2
activity than do nonsmokers and women and
that oral contraceptive use inhibits CYP1A2
activity. It is one of the ﬁrst investigations to
report positive correlations between serum
PCB concentrations and CYP1A2 activity,
despite the relatively low PCB body burdens of
this population and the lack of data on individ-
ual non-ortho-substituted PCBs or dioxins.
While serum PCB concentrations serve as a
marker of internal dose, CYP1A2 activity indi-
cates an early biological effect of such exposure,
at least among those persons genetically predis-
posed. Although the health implications in
humans remain uncertain, CYP1A2 is involved
in the metabolic activation of some carcino-
gens, and consequently, individual differences
may reflect susceptibility to environmentally
related cancer risk (Landi et al. 1999). The
data support the notion that human exposure
to PCBs may induce CYP1A2 activity and that
the CBT is a useful tool to monitor such
effects in vivo.
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